ADVERTISEMENT

Gujarat Themis Biosyn - New Business Model To Drive Topline, Margin: HDFC Securities Initiates Coverage

The company is engaged in manufacturing of active pharma ingredients namely Rifamycin S and Rifamycin O.

<div class="paragraphs"><p>Close view of capsules. (Photo: freepik)</p></div>
Close view of capsules. (Photo: freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More